Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsight

The microbiology testing market is experiencing steady growth, driven by the increasing prevalence of infectious diseases and the rising demand for rapid and accurate diagnostic testing. Growing healthcare expenditure and improvements in laboratory infrastructure are supporting the adoption of advanced microbiological testing technologies. In addition, stringent food, pharmaceutical, and environmental safety regulations are increasing the need for routine microbial testing. Technological advancements, including automated systems, molecular diagnostics, and rapid testing methods, are further enhancing market expansion.

New York, USA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsight

The microbiology testing market is experiencing steady growth, driven by the increasing prevalence of infectious diseases and the rising demand for rapid and accurate diagnostic testing. Growing healthcare expenditure and improvements in laboratory infrastructure are supporting the adoption of advanced microbiological testing technologies. In addition, stringent food, pharmaceutical, and environmental safety regulations are increasing the need for routine microbial testing. Technological advancements, including automated systems, molecular diagnostics, and rapid testing methods, are further enhancing market expansion. 

DelveInsight’s Microbiology Testing Market Insights report provides the current and forecast market analysis, individual leading microbiology testing companies’ market shares, challenges, microbiology testing market drivers, barriers, trends, and key microbiology testing companies in the market.

Microbiology Testing Market Summary

• 2025 Microbiology Testing Market Size: USD 6.3 Billion
• 2034 Projected Microbiology Testing Market Size: USD 13.7 Billion
• Microbiology Testing Market Growth Rate (2026-2034): ~9% 
• Largest Microbiology Testing Market: North America
• Largest Product Segment: Instruments Category
• Key Companies in the Microbiology Testing Market: Thermo Fisher Scientific Inc., bioMérieux SA, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Merck KGaA, Abbott Laboratories, QIAGEN N.V., Bruker Corporation, Bio-Rad Laboratories, Inc., Hologic, Inc., Agilent Technologies, Inc., NEOGEN Corporation, Shimadzu Corporation, DiaSorin S.p.A. (Luminex), Charles River Laboratories, and others. 

To read more about the future of the microbiology testing market, get a snapshot @ https://www.delveinsight.com/report-store/microbiology-testing-market

Key Factors Contributing to the Rise in Growth of the Microbiology Testing Market

• Rising Burden of Infectious Diseases: The increasing prevalence of bacterial, viral, fungal, and parasitic infections is driving demand for accurate and timely microbiological testing. Growing concerns around emerging and re-emerging pathogens are further supporting the need for advanced diagnostic solutions.
• Growing Adoption of Molecular Diagnostic Technologies: Rapid molecular techniques, including PCR, nucleic acid amplification, and sequencing-based methods, are improving the speed and accuracy of pathogen identification. Their ability to detect infections at an early stage is encouraging wider adoption across clinical laboratories.
• Increasing Antimicrobial Resistance (AMR): The global rise in antimicrobial-resistant pathogens is creating greater demand for microbial identification and antimicrobial susceptibility testing. These tests help healthcare providers select appropriate therapies and support more effective antimicrobial stewardship.
• Expansion of Clinical Diagnostic Laboratories: The expansion of hospitals, diagnostic centers, and laboratory networks, particularly across emerging economies, is increasing access to microbiology testing. Investments in laboratory automation and advanced diagnostic infrastructure are further strengthening market growth.
• Growing Food and Beverage Safety Requirements: Stricter regulations governing food safety are increasing the use of microbiological testing to identify pathogens, spoilage organisms, and contamination. Food manufacturers are adopting routine testing to comply with regulatory standards and maintain product quality.
• Increasing Pharmaceutical and Biotechnology Production: Rising pharmaceutical and Antimicrobial Susceptibility Testing manufacturing is driving demand for microbiological testing throughout production and quality-control processes. Sterility testing, microbial limits testing, and environmental monitoring are increasingly important for ensuring product safety and regulatory compliance.
• Technological Advancements and Laboratory Automation: Automated microbiology systems, rapid microbial identification platforms, and AI-enabled analytical technologies are improving laboratory efficiency and reducing testing turnaround times. These innovations are supporting higher testing volumes while minimizing manual intervention.
• Growing Awareness of Preventive Healthcare and Early Diagnosis: Increasing awareness of infection prevention and early disease detection is encouraging the use of diagnostic testing. Greater emphasis on surveillance and routine screening is also expanding the application of microbiology testing beyond traditional hospital settings.
• Expansion of Testing in Environmental and Water Monitoring: Growing concerns regarding water quality, environmental contamination, and public health are increasing demand for microbiological testing of water and environmental samples. Regulatory monitoring and infrastructure development are further supporting this application.

Get a sneak peek at the microbiology testing market dynamics @ Microbiology Testing Market Trends

Regional Microbiology Testing Market Insights

North America

• North America captured a 42% share of the global microbiology testing market in 2025 and is anticipated to maintain its leading position throughout the forecast period. 
• The region’s dominance is supported by the high prevalence and awareness of infectious diseases and antimicrobial resistance, widespread adoption of advanced molecular and automated testing technologies, well-established healthcare and reimbursement systems, stringent food and pharmaceutical safety regulations, and the strong presence of major diagnostic companies. 
• The United States, in particular, has an extensive and technologically advanced network of hospitals, reference laboratories, and diagnostic facilities that conduct substantial volumes of microbiology testing and rapidly adopt molecular diagnostics, mass spectrometry, and laboratory automation. Favorable reimbursement policies and high healthcare spending further enable investments in these advanced technologies. 
• North America also remains at the forefront of antimicrobial resistance management, rapid syndromic and molecular testing adoption, and regulatory requirements for microbiological testing across the food and pharmaceutical industries. 
• In addition, the region serves as a major launch market for innovative diagnostic technologies, many of which receive regulatory clearance and enter commercial use in the United States before other markets. 
• The presence of leading diagnostics companies, supported by strong research capabilities and well-developed public health laboratory infrastructure, further strengthens the region’s market position.

Europe

• Europe is expected to maintain a significant share of the global microbiology testing market through 2034, supported by well-established healthcare systems, advanced diagnostic infrastructure, stringent regulatory standards, and a strong focus on infectious disease surveillance and antimicrobial resistance management.
• The region’s market is driven by the high prevalence of infectious diseases, increasing awareness of antimicrobial resistance, widespread adoption of molecular and automated microbiology testing technologies, and robust healthcare expenditure across major markets such as Germany, the United Kingdom, France, Italy, and Spain.
• Europe has a highly developed network of hospitals, reference laboratories, research institutions, and public health laboratories that conduct substantial volumes of microbiology testing. The growing adoption of rapid molecular diagnostics, automated laboratory systems, mass spectrometry, and syndromic testing is further supporting market development.
• The region also maintains strong regulatory requirements for microbiological testing across the food, pharmaceutical, and healthcare sectors. Strict European standards for food safety, pharmaceutical quality control, infection prevention, and environmental monitoring continue to generate demand for reliable and advanced microbiology testing solutions.
• In addition, Europe remains an important center for antimicrobial resistance surveillance and infectious disease monitoring, with healthcare institutions and public health authorities increasingly emphasizing rapid pathogen identification and antimicrobial susceptibility testing. These efforts are encouraging the adoption of faster and more accurate diagnostic technologies.
• Germany, the United Kingdom, and France represent key markets due to their established healthcare infrastructure, strong research capabilities, and extensive laboratory networks. Meanwhile, countries across Southern and Eastern Europe are expanding diagnostic capacity and modernizing laboratory facilities, creating additional opportunities for market growth.
• The presence of leading diagnostic companies, well-developed healthcare systems, strong regulatory frameworks, and continued investments in laboratory automation and molecular diagnostics is expected to strengthen Europe’s position in the global microbiology testing market throughout the forecast period.

Asia-Pacific

• Asia-Pacific is expected to record the fastest CAGR in the microbiology testing market through 2034, positioning the region as a key driver of global market expansion. 
• Growth is being supported by large and growing populations, a substantial burden of infectious diseases, improving healthcare access and diagnostic laboratory infrastructure, rising healthcare spending, and increasingly stringent food and pharmaceutical safety regulations across China, India, Japan, and Southeast Asia. 
• The region’s significant disease burden, combined with the modernization and expansion of diagnostic laboratories, is creating sustained demand for microbiology testing. Rising incomes, broader healthcare coverage, and increased public and private investment are further strengthening laboratory capacity and access to advanced testing technologies.
• Governments and private healthcare providers are also investing in laboratory facilities, testing instruments, skilled personnel, and public health surveillance capabilities, while heightened regulatory requirements are increasing demand for food and pharmaceutical safety testing. 
• China benefits from its large population, expanding diagnostics industry, and strong manufacturing base; India is supported by its substantial infectious disease burden and rapidly growing diagnostic laboratory sector; and Japan offers a mature testing environment supported by its aging population and advanced healthcare infrastructure. 
• Demand for both sophisticated and cost-effective testing solutions is creating opportunities for international and regional market participants. 
• As a result, the Asia-Pacific microbiology testing market is anticipated to grow faster than the global market across all major segments.

To know more about why North America is leading the market growth in the microbiology testing market, get a snapshot of the Microbiology Testing Market Analysis

Recent Developmental Activities in the Microbiology Testing Market

• In September 2025, bioMérieux received United States Food and Drug Administration clearance for anterior nasal swab testing on its BIOFIRE Spotfire platform, extending the Spotfire respiratory and sore-throat panel, a rapid multiplex polymerase chain reaction test that detects common viral and bacterial causes within fifteen minutes, to a more comfortable sample-collection method.
• In February 2025, bioMérieux received United States Food and Drug Administration clearance for the BIOFIRE FILMARRAY Gastrointestinal Panel Mid, a midplex molecular panel that tests for eleven of the most common bacteria, viruses, and parasites associated with gastroenteritis from a single sample with results within one hour.
• In 2025, QIAGEN received United States Food and Drug Administration clearance for its QIAstat-Dx Rise, a higher-throughput syndromic testing system that adds automation and faster turnaround for laboratories seeking to scale molecular syndromic testing.

What is Microbiology Testing?

Microbiology testing refers to the laboratory analysis of biological samples, products, or environmental materials to detect, identify, and quantify microorganisms such as bacteria, viruses, fungi, and parasites. It is widely used in healthcare, pharmaceuticals, food and beverage, water testing, and environmental monitoring to identify potential sources of infection or contamination. Microbiology testing may involve techniques such as culture-based methods, microscopy, antimicrobial susceptibility testing, polymerase chain reaction (PCR), and immunological assays. In clinical settings, these tests support the diagnosis of infectious diseases and help guide appropriate treatment, while in industrial and pharmaceutical applications, they are used to ensure product quality, safety, sterility, and regulatory compliance.

Microbiology Testing Market Report Metrics	Details
Coverage	Global
Study Period	2023–2034
Microbiology Testing Market CAGR	~9%
Microbiology Testing Market Size by 2034	USD 13.7 Billion
Key Microbiology Testing Companies	Thermo Fisher Scientific Inc., bioMérieux SA, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Merck KGaA, Abbott Laboratories, QIAGEN N.V., Bruker Corporation, Bio-Rad Laboratories, Inc., Hologic, Inc., Agilent Technologies, Inc., NEOGEN Corporation, Shimadzu Corporation, DiaSorin S.p.A. (Luminex), Charles River Laboratories, and others

Microbiology Testing Market Assessment

• Microbiology Testing Market Segmentation
  • Microbiology Testing Market Segmentation By Product: Instruments, Reagents and Consumables, and Software and Services
  • Microbiology Testing Market Segmentation By Test Type: Bacterial, Viral, Fungal, and Parasitic
  • Microbiology Testing Market Segmentation By Technology: Culture-Based Testing, Molecular Diagnostics, Immunoassay, and Others
  • Microbiology Testing Market Segmentation By Application: Clinical Diagnostics, Food Testing, Pharmaceutical and Biotechnology, and Environmental
  • Microbiology Testing Market Segmentation By End Users: Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and The Food and Beverage Industry
  • Microbiology Testing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the microbiology testing market are set to emerge as the trendsetter explore @ Microbiology Testing Market Size

Table of Contents 

1	Microbiology Testing Market Report Introduction
2	Microbiology Testing Market Executive Summary
3	Microbiology Testing Market Key Factors Analysis
4	Impact Analysis
5	Regulatory Analysis
6	Microbiology Testing Market Porter’s Five Forces Analysis
7	Microbiology Testing Market Assessment
8	Competitive Landscape
9	Startup Funding & Investment Trends
10	Microbiology Testing Market Company and Product Profiles
11	KOL Views
12	Project Approach
13	About DelveInsight
14	Disclaimer & Contact Us

Interested in knowing the microbiology testing market share by 2034? Click to get a snapshot of the Top Microbiology Testing Companies

Related Reports

Antimicrobial Susceptibility Testing Market

Antimicrobial Susceptibility Testing Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key antimicrobial susceptibility testing companies, including bioMérieux SA, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Beckman Coulter, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, Accelerate Diagnostics, Inc., Luminex Corporation, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, HiMedia Laboratories Pvt. Ltd., Hardy Diagnostics, Liofilchem S.r.l., Merck KGaA, Charles River Laboratories International, Inc., QIAGEN N.V., Cepheid, Inc., and others.

Molecular Diagnostics Market

Molecular Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key molecular diagnostics companies such as Hoffmann-La Roche Ltd., Hologic, Inc., bioMérieux SA, Abbott, QIAGEN, BD, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher, Myriad Genetics, Inc., Agilent Technologies Inc., Illumina Inc., DiaSorin Inc., MDxHealth, Genetic Signatures, Biocartis, Exact Sciences Corporation, Amoy Diagnostics Co. Ltd., Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, and others.

Point-of-Care Molecular Diagnostics Market

Point-of-Care Molecular Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key point-of-care molecular diagnostics companies such as Danaher Corporation, F. Hoffmann-La Roche Ltd, Abbott Laboratories, bioMérieux SA, QIAGEN N.V., Becton, Dickinson and Company, Hologic, Inc., QuidelOrtho Corporation, Thermo Fisher Scientific Inc., SD Biosensor, Inc., and others.

Clinical Diagnostics Market

Clinical Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key clinical diagnostics companies such as BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG, Hologic, Inc., Qiagen NV, Quest Diagnostics Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Inc., BioReference Laboratories, Laboratory Corporation of America® Holdings, DiaSorin, PerkinElmer Inc., FUJIFILM Corporation, and others.

Immunoassay Market

Immunoassay Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key immunoassay companies, including Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, ALPCO, Autobio, PHC Corporation, Trivitorn Healthcare, Werfen, Danaher Corporation, Sysmex Corporation, Awareness Technology Inc, ZECEN Biotech Co., Quidel Corporation, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us

Shruti Thakur 

info@delveinsight.com 

+14699457679